Future studies are needed to reconcile the underlying differences between tumor tissue and basal PTC cell line GPX4 expression levels and in vitro responses to pharmacologic inhibition of GPX4 within an emulated 3D thyroid tumor microenvironment in vitro and in vivo
Dulaglutide (Trulicity), administered weekly, has a half-life of approximately 5 days, meaning it takes roughly 3-4 weeks (about 5 half-lives) for 97% elimination
- **Drug acquisition**: Ensure the drug is obtained through an approved DME supplier or pharmacy network if required by the payer
Additionally, participants in the tirzepatide group were more likely than those in the semaglutide group to have weight reductions of 10%, 15%, 20%, and 25%
Some researchers describe a unique quality to the satiety, not just feeling less hungry, but feeling genuinely indifferent to food